Espaven Enzymatic 40mg 130mg 25mg 5 mg 50 tabs
Substance = Dimethicone, Pancreatin, Ox Bile
INDICATIONS: Dyspepsia excess food intake, absolute or relative enzyme deficiencies .
Steatorrhea of malabsorption . Prevention of exacerbations of irritable bowel syndrome . Postprandial bloating and flatulence . Pancreatic insufficiency . Poor digestion of fats .
Human Pharmacokinetics : The content provides the components pancreatin enzyme for the degradation of proteins, carbohydrates and fats , the latter previously emulsified by bile salts of ox bile extract .
It acts as an adjunct or replacement for proper absorption digestive process .
Dimethicone works by decreasing the surface tension of gastrointestinal mucus , preventing gas retention as well as flatulence and bloating fermentation accompanying indigestion.
The cellulase enzyme obtained from Aspergillus niger , hydrolyzed cellulose, it can exacerbate intestinal activity and the intensification of irritable bowel syndrome .
No pharmacokinetic characteristics studied .
Hypersensitivity to the components of the formula.
PRECAUTIONS: Patients who are hypersensitive to the components of the formula , and bile duct obstruction , acute hepatitis, severe intestinal perforation .
The latter due to the components of the formula as the dry extract of ox bile , can stimulate liver function and aggravate the symptoms .
RESTRICTIONS OF USE DURING PREGNANCY AND BREASTFEEDING
Although not documented with certainty teratogenic effects on output and the mother, are not recommended ENZYMATIC ® ESPAVEN during the first trimester of pregnancy and during lactation provided that clearly needed , assessing risk-benefit .
ADVERSE REACTIONS : In excessive doses can cause diarrhea . Can generate hypersensitivity to any component of the formula.
DRUG INTERACTIONS AND OTHER GENDER : It has been suggested the possible interaction with phenytoin dimethicone and with ascarbosa pancreatin , cimetidine , ciprofloxacin , famotidine , folic acid , nizatidine and ranitidine .
CHANGES IN RESULTS OF LABORATORY TESTS have not been observed to date.
PRECAUTIONS IN RELATION TO EFFECTS Carcinogenesis, Mutagenesis , Impairment of Fertility: There have been observed .
DOSAGE AND ADMINISTRATION: 1 or 2 tablets after each meal .
MANIFESTATIONS AND MANAGEMENT OF OVERDOSE OR ACCIDENTAL INGESTION : Not documented .
Box of 50 enteric-coated tablets .
RECOMMENDED STORAGE : Store at room temperature not more than 30 ° C and dry .
LEGENDS OF PROTECTION
Exclusively for medical literature .
Keep out of reach of children .
If you require more detailed information can be obtained from your medical representative or directly to the Medical Director of Valeant Pharmaceuticals , S. A. C. V.
- Drug Name: ESPAVEN ENZYMATIC
- Comparable drug patent: ENZYMATIC ESPAVEN
- Active Ingredients: DIMETHICONE / PANCREATIN / OX BILE / Cellulase
- Presentation: PILLS
- Concentration: 40mg / 130mg / 25mg / 5mg
- Extended-release tablets: No
- Laboratory: Valeant
- Box with 50 pills
- Made in Mexico